Nuo Therapeutics, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

OQB
Scott M. Pittman amends Schedule 13D regarding Nuo Therapeutics, detailing loan agreements and warrant issuances.
OQB
Nuo Therapeutics, Inc. has secured a $200,000 loan from insider Scott M. Pittman, who increased his beneficial ownership to 11.6% through new warrants.